Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

The endocannabinoid system affects oil production and inflammation in skin cells.

Different treatments are effective for hair loss conditions, but results vary by individual factors.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Systemic diseases can cause hair loss, which is often reversible with treatment.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Thyroid problems can cause hair loss and change hair texture.

COVID-19 infection may cause hair loss.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

β-catenin in the dermal papilla is crucial for normal hair growth and repair.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

Many new moms lose hair after childbirth due to hormonal changes, but it usually grows back within a year.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

Oral minoxidil helps treat hair loss and has reversible side effects.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Cathepsin L is essential for normal hair growth and development.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

People with HIV and low T cell counts have more hair and scalp problems.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.